Sartorius Stedim Biotech S.A. (DIM.PA)
EUR 202.4
(0.55%)
EUR 202.4
(0.55%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.56 Billion EUR | 246.65% |
| 2022 | 1.02 Billion EUR | 155.92% |
| 2021 | 401.89 Million EUR | -23.74% |
| 2020 | 527.02 Million EUR | 389.34% |
| 2019 | 107.7 Million EUR | -14.29% |
| 2018 | 125.66 Million EUR | -1.15% |
| 2017 | 127.11 Million EUR | 88.14% |
| 2016 | 67.56 Million EUR | -21.83% |
| 2015 | 86.42 Million EUR | -1.15% |
| 2014 | 87.43 Million EUR | -32.72% |
| 2013 | 129.95 Million EUR | 14.31% |
| 2012 | 113.68 Million EUR | 13.56% |
| 2011 | 100.11 Million EUR | -2.57% |
| 2010 | 102.75 Million EUR | 17.24% |
| 2009 | 87.64 Million EUR | -41.59% |
| 2008 | 150.05 Million EUR | -2.46% |
| 2007 | 153.83 Million EUR | 182.85% |
| 2006 | 54.38 Million EUR | -10.43% |
| 2005 | 60.72 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 2.2 Billion EUR | -4.7% |
| 2024 Q2 | 2.46 Billion EUR | -1.15% |
| 2024 Q1 | 2.49 Billion EUR | -30.06% |
| 2023 Q3 | 3.69 Billion EUR | 195.91% |
| 2023 Q1 | 1.21 Billion EUR | 17.92% |
| 2023 Q2 | 1.24 Billion EUR | 2.95% |
| 2023 Q4 | 3.56 Billion EUR | -3.5% |
| 2023 FY | 3.56 Billion EUR | 246.65% |
| 2022 Q1 | 465.8 Million EUR | 15.9% |
| 2022 Q4 | 1.02 Billion EUR | 0.82% |
| 2022 Q3 | 1.02 Billion EUR | 77.07% |
| 2022 Q2 | 576.1 Million EUR | 23.68% |
| 2022 FY | 1.02 Billion EUR | 155.92% |
| 2021 Q3 | 416.3 Million EUR | 17.2% |
| 2021 Q4 | 401.89 Million EUR | -3.46% |
| 2021 Q1 | 459.8 Million EUR | -12.76% |
| 2021 Q2 | 355.2 Million EUR | -22.75% |
| 2021 FY | 401.89 Million EUR | -23.74% |
| 2020 FY | 527.02 Million EUR | 389.34% |
| 2020 Q2 | 243.3 Million EUR | 426.62% |
| 2020 Q3 | 164.7 Million EUR | -32.31% |
| 2020 Q4 | 527.02 Million EUR | 219.99% |
| 2020 Q1 | 46.2 Million EUR | -57.1% |
| 2019 Q3 | 106.2 Million EUR | -26.91% |
| 2019 FY | 107.7 Million EUR | -14.29% |
| 2019 Q2 | 145.3 Million EUR | 28.81% |
| 2019 Q1 | 112.8 Million EUR | -10.23% |
| 2019 Q4 | 107.7 Million EUR | 1.41% |
| 2018 Q1 | 116.8 Million EUR | -8.12% |
| 2018 FY | 125.66 Million EUR | -1.15% |
| 2018 Q4 | 125.66 Million EUR | -8.88% |
| 2018 Q3 | 137.9 Million EUR | -12.17% |
| 2018 Q2 | 157 Million EUR | 34.42% |
| 2017 Q2 | 166.8 Million EUR | 127.87% |
| 2017 FY | 127.11 Million EUR | 88.14% |
| 2017 Q1 | 73.2 Million EUR | 10.95% |
| 2017 Q4 | 127.11 Million EUR | -13.99% |
| 2017 Q3 | 147.8 Million EUR | -11.39% |
| 2016 FY | 67.56 Million EUR | -21.83% |
| 2016 Q1 | 74.6 Million EUR | -12.15% |
| 2016 Q2 | 108.5 Million EUR | 45.44% |
| 2016 Q3 | 93.1 Million EUR | -14.19% |
| 2016 Q4 | 65.97 Million EUR | -29.14% |
| 2015 Q4 | 84.92 Million EUR | -20.93% |
| 2015 Q3 | 107.4 Million EUR | -3.5% |
| 2015 Q2 | 111.3 Million EUR | 27.2% |
| 2015 Q1 | 87.5 Million EUR | 1.9% |
| 2015 FY | 86.42 Million EUR | -1.15% |
| 2014 FY | 87.43 Million EUR | -32.72% |
| 2014 Q4 | 85.87 Million EUR | -28.38% |
| 2014 Q3 | 119.9 Million EUR | -9.24% |
| 2014 Q2 | 132.1 Million EUR | 2.4% |
| 2014 Q1 | 129 Million EUR | -1.8% |
| 2013 Q3 | 117.2 Million EUR | -16.7% |
| 2013 Q4 | 131.35 Million EUR | 12.08% |
| 2013 Q2 | 140.7 Million EUR | 766.82% |
| 2013 Q1 | -21.1 Million EUR | 24.12% |
| 2013 FY | 129.95 Million EUR | 14.31% |
| 2012 Q2 | 146.1 Million EUR | 0.0% |
| 2012 FY | 113.68 Million EUR | 13.56% |
| 2012 Q4 | -27.8 Million EUR | 0.0% |
| 2011 Q2 | 114.4 Million EUR | 0.0% |
| 2011 FY | 100.11 Million EUR | -2.57% |
| 2010 Q2 | 127.6 Million EUR | 0.0% |
| 2010 FY | 102.75 Million EUR | 17.24% |
| 2009 FY | 87.64 Million EUR | -41.59% |
| 2009 Q4 | 87.64 Million EUR | 0.0% |
| 2008 FY | 150.05 Million EUR | -2.46% |
| 2007 FY | 153.83 Million EUR | 182.85% |
| 2006 FY | 54.38 Million EUR | -10.43% |
| 2005 FY | 60.72 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Crossject Société Anonyme | 13.88 Million EUR | -25577.35% |
| Safe Orthopaedics SA | 9.13 Million EUR | -38946.107% |
| Spineway SA | 802 Thousand EUR | -444451.122% |
| Amplitude Surgical SA | 78.54 Million EUR | -4439.008% |
| EssilorLuxottica Société anonyme | 9.09 Billion EUR | 60.817% |
| bonyf N.V. | 65.04 Thousand EUR | -5481519.286% |